M1414 Medial rsn no pdl1 bef first therapy
Also known as: no PD-L1 testing reason, medical exception PD-L1, med rsn no pdl1
Performance measure documenting medical reason why PD-L1 testing was not performed before first-line immunotherapy initiation. Captures appropriate exceptions.
In Plain Language
Doctor's reason for skipping cancer protein test; Medical exception to tumor testing
Clinical Context
Documents medical contraindications to PD-L1 testing such as limited tissue availability or rapidly progressive disease requiring immediate treatment.
RVU Information
CPT M1414 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
M-codes cover quality measures and performance reporting. They are used in value-based care programs to track whether specific clinical actions were taken. Documentation must support that the measured action was performed or a valid exclusion applies.
Specialties
Frequently Asked Questions
What is CPT code M1414?
CPT M1414 (Medial rsn no pdl1 bef first therapy) is a M Codes code. Performance measure documenting medical reason why PD-L1 testing was not performed before first-line immunotherapy initiation. Captures appropriate exceptions.
Is M1414 covered by insurance?
M1414 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Documents medical contraindications to PD-L1 testing such as limited tissue availability or rapidly progressive disease requiring immediate treatment.
When is CPT M1414 used?
Documents medical contraindications to PD-L1 testing such as limited tissue availability or rapidly progressive disease requiring immediate treatment.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.